Growth Metrics

Rigel Pharmaceuticals (RIGL) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 41.97%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 41.97%
Dec 31, 2025 153.10%
Sep 30, 2025 51.12%
Jun 30, 2025 86.10%
Mar 31, 2025 34.25%
Dec 31, 2024 38.74%
Sep 30, 2024 37.31%
Jun 30, 2024 58.86%
Mar 31, 2024 -30.06%
Dec 31, 2023 26.79%
Sep 30, 2023 26.22%
Jun 30, 2023 27.85%
Mar 31, 2023 -38.16%
Dec 31, 2022 27.68%
Sep 30, 2022 -18.33%
Jun 30, 2022 13.17%
Mar 31, 2022 -15.97%
Dec 31, 2021 -108.26%
Sep 30, 2021 3.91%
Jun 30, 2021 16.66%
Mar 31, 2021 54.56%
Dec 31, 2020 9.40%
Sep 30, 2020 7.07%
Jun 30, 2020 2.81%
Mar 31, 2020 49.24%
Dec 31, 2019 -3.14%
Sep 30, 2019 20.22%
Jun 30, 2019 -15.04%
Mar 31, 2019 -0.26%
Dec 31, 2018 31.12%
Sep 30, 2018 -52.30%
Jun 30, 2018 -22.47%
Mar 31, 2018 -10.26%
Dec 31, 2017 -5.04%
Sep 30, 2017 5.59%
Jun 30, 2017 8.98%
Mar 31, 2017 10.39%
Dec 31, 2016 2.43%
Sep 30, 2016 1.70%
Jun 30, 2016 15.92%
Mar 31, 2016 11.94%
Dec 31, 2015 20.75%
Sep 30, 2015 35.83%
Jun 30, 2015 17.46%
Mar 31, 2015 7.75%
Dec 31, 2014 4.69%
Sep 30, 2014 -5.38%
Jun 30, 2014 -5.74%
Mar 31, 2014 -2.38%
Dec 31, 2013 4.86%
Sep 30, 2013 -35.22%
Jun 30, 2013 -41.65%